Cancer

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
(MedPage Today) -- The cancer diagnosis came as a shock, disrupting Morgan Newman's plans for launching her life. It was 2015, and she was working as a dental assistant in Des Moines, Iowa, while studying to become a social worker. After an abnormal...
Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor
(MedPage Today) -- NASHVILLE, Tenn. -- Four years ago, Tennessee became the first state to allow adults to buy the antiparasitic drug ivermectin from a pharmacy without first seeing a doctor. Pharmacies can use a pre-written, blanket prescription...
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
(MedPage Today) -- A new study showed a "dose response risk relationship" between alcohol consumption and pancreatic cancer. (International Journal of Alcohol and Drug Research) Brain tumors diagnosed in 11 nurses at Newton-Wellesley Hospital...
Triplet Could Become a New Standard in Tough-to-Treat CLL
(MedPage Today) -- Fixed-duration therapy with pirtobrutinib (Jaypirca) plus venetoclax (Venclexta) and rituximab improved progression-free survival (PFS) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL), according to interim...
Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths
(MedPage Today) -- Note that some links may require registration or subscription. Brain tumors diagnosed in 11 nurses at Newton-Wellesley Hospital in suburban Boston were not caused by any exposures to chemicals, radiation, or anything else at...
FDA Alerts on Shortage of Breast Biopsy Needles
(MedPage Today) -- The FDA informed healthcare providers about disruptions in the supply of stereotactic breast biopsy needles that will likely persist through March 2027. According to the agency, the disruption is expected to impact patient care...
Studies Raise New Questions in HR-Positive, HER2-Negative Breast Cancer
(MedPage Today) -- Several studies presented at this year's American Society of Clinical Oncology (ASCO) annual meeting highlighted emerging strategies for hormone receptor (HR)-positive, HER2-negative metastatic breast cancer, including early...
Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer
(MedPage Today) -- Reminders, or "nudges," to both oncology clinicians and patients led to a significant increase in difficult conversations about poor-prognosis cancers, a large randomized study showed. Involving more than 1,000 patients and...
In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes
(MedPage Today) -- Replacing two high-dose chemotherapy courses with blinatumomab (Blincyto) significantly improved event-free survival (EFS) in pediatric patients with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), an interim...
Talquetamab Regimens Boost Survival in Multiple Myeloma
(MedPage Today) -- Talquetamab (Talvey) plus daratumumab (Darzalex) with or without pomalidomide (Pomalyst) significantly improved survival outcomes over an active regimen for relapsed or refractory multiple myeloma, a phase III trial showed....